FIELD: chemistry of peptides, medicine, cardiology, pharmacy.
SUBSTANCE: invention relates to medicinal agents used for treatment of cardiovascular system diseases. Invention proposes new tetrapeptide alanyl-glutamyl-aspartyl-arginine of the general formula: Ala-Glu-Asp-Arg of the sequence 1 [SEQ ID NO:1] eliciting biological activity and displaying in recovery of function of myocardium. Invention proposes pharmacological agent comprising the effective dose of tetrapeptide alanyl-glutamyl-aspartyl-arginine of the general formula: Ala-Glu-Asp-Arg as an active peptide agent of the sequence 1 [SEQ ID NO:1] that elicits biological activity and displaying in recovery of function of myocardium. Using new tetrapeptide Ala-Glu-Asp-Arg as component of medicinal agent promotes to recovery of function of myocardium. Invention can be used as an agent recovering function of myocardium in treatment of different form of this pathology.
EFFECT: valuable medicinal properties of peptide.
4 cl, 9 tbl, 1 dwg, 9 ex
Authors
Dates
2005-07-10—Published
2004-06-22—Filed